MYOTON PHENYLBUTAZONE GRANULES

Main information

  • Trade name:
  • VR MYOTON PHENYLBUTAZONE GRANULES
  • Available from:
  • VR
  • Pharmaceutical form:
  • ORAL GRANULES, PELLETS
  • Units in package:
  • 100x2.5g Sachets
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • JUROX

Documents

Localization

  • Available in:
  • VR MYOTON PHENYLBUTAZONE GRANULES
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL
  • Therapeutic area:
  • NSAID
  • Therapeutic indications:
  • MUSCULOSKELETAL CONDITIONS | ARTHRITIS | ARTHROSIS | BURSITIS | EXTERNAL MYOPATHY | INFLAMATION OF SOFT TISSUES AN | OSTEITIS | OSTEOARTHRITIS | TENDON AND LIGAMENT SPRAINS | TENDONITIS | TENOSYNOVITIS | TRAUMATIC JOINT AND CONNECTIVE
  • Product summary:
  • For the relief of pain and inflammation in arthritic and musculo-skeletal conditions in horses.DO not administer to horses with cardiac, renal or liver disease. Discontinue therapy if signs of gastric or oral ulceration, inappetence or vascular disorders occur. Phenylbutazone should not be used in conjunction with other drug therapy especially NSAI

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered and available
  • Authorization number:
  • 36279/0104
  • Authorization date:
  • 23-07-2004
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

VR Myoton Phenylbutazone Granules

25 March 04

page 1/2

Carton label

PRESCRIPTION ANIMAL REMEDY

KEEP OUT OF REACH OF CHILDREN

Info

pest

Verified

FOR ANIMAL TREATMENT ONLY

VR

MYOTON PHENYLBUTAZONE GRANULES

ACTIVE CONSTITUENT:

Each 2.5g (one sachet) contains 1 g PHENYLBUTAZONE

For the relief of pain and inflammation in arthritic and musculo-skeletal conditions in horses

100 Sachets

JUROX

DIRECTIONS FOR USE:

Do not administer to horses with cardiac, renal or liver disease. Discontinue therapy if signs of

gastric or oral ulceration, inappetance or vascular disorders occur. Phenylbutazone should not

be used in conjunction with other drug therapy especially NSAIDs or coumarin anticoagulants.

Horses (450 kg bodyweight): Give 1 – 4 sachets daily for 2 days, then reduce dose to lowest level

which produces the desired clinical response, or as directed by the veterinary surgeon. (Give 2.2 – 8.8

mg/kg bodyweight daily for 2 days then reduce).

Ponies (225 kg bodyweight): Give 1 sachet daily for 2 days, then reduce dose to lowest level which

produces the desired clinical response, or as directed by the veterinary surgeon. (Give 2.2 mg/kg

bodyweight daily for 2 days then reduce).

MEAT WITHHOLDING PERIOD (HORSES):

NOT TO BE USED in horses intended for human consumption

New Zealand Information:

In New Zealand it is a legal requirement that this product is not used in any animal

producing or intended to produce food for human consumption.

Registered to Jurox New Zealand Limited, 38A Firth St, Drury, Auckland. Ph 0800 587 696

Registered pursuant to the ACVM Act 1997 No. A3130

Prescription Animal Remedy (P.A.R.) Class 1,

for use only under the authority or prescription of a veterinarian.

See www.nzfsa.govt.nz/acvm for registration conditions.

FIRST AID

If poisoning occurs, contact a doctor or Poisons Information Centre. Phone

Australia131126, New Zealand 0800 764 766.

Made in Australia by

Jurox Pty Ltd, 85 Gardiners Rd, Rutherford NSW 2320 Australia. Infoline 1800 023 312

APVMA Approval No. 36279/1g/0104

DISPOSE of container by wrapping in paper and putting in garbage.

STORE below 30

C (Room Temperature).

EXP.

VR Myoton Phenylbutazone Granules

25 March 04

page 2/2

Sachet

PRESCRIPTION ANIMAL REMEDY

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

VR

MYOTON PHENYLBUTAZONE GRANULES

Each 2.5g (one sachet) contains 1 g PHENYLBUTAZONE

For the relief of pain and inflammation in arthritic and musculo-skeletal conditions in horses

2.5 g NET

JUROX

DIRECTIONS:

See carton for full Directions.

Horses (450 kg bodyweight): Give 2.2 – 8.8 mg/kg bodyweight daily for 2 days then reduce.

Ponies (225 kg bodyweight): Give 2.2 mg/kg bodyweight daily for 2 days then reduce.

MEAT WITHHOLDING PERIOD (HORSES):

NOT TO BE USED in horses intended for human consumption

Jurox Pty Ltd, 85 Gardiners Rd, Rutherford NSW 2320 Australia. Infoline 1800 023 312

APVMA 36279/1g/0104

Registered to Jurox New Zealand Limited, 38A Firth St, Drury, Auckland. Ph 0800 587 696

(P.A.R.) Class 1, ACVM No. A3130

STORE below 30

C (Room Temperature).

EXP.

22-1-2019

Modification of the existing maximum residue levels for aclonifen in celeriacs and certain fresh herbs

Modification of the existing maximum residue levels for aclonifen in celeriacs and certain fresh herbs

Published on: Mon, 21 Jan 2019 In accordance with Article 6 of Regulation (EC) No 396/2005, the applicants Landesanstalt für Landwirtschaft und Gartenbau Sachsen‐Anhalt (LSA) and Dienstleistungszentrum Ländlicher Raum Rheinpfalz (DLR), respectively, submitted a request to the competent national authority in Germany to modify the existing maximum residue levels (MRL) for the active substance aclonifen in chives, parsley, celery leaves/dill leaves, thyme/savoury and in celeriacs/turnip‐rooted celery. The ...

Europe - EFSA - European Food Safety Authority EFSA Journal

3-10-2018

Koning met minister De Jonge op werkbezoek in het kader van kwaliteit verpleeghuiszorg

Koning met minister De Jonge op werkbezoek in het kader van kwaliteit verpleeghuiszorg

Zijne Majesteit de Koning heeft woensdag 3 oktober 2018 samen met vicepremier en minister De Jonge van Volksgezondheid, Welzijn en Sport (VWS) een werkbezoek gebracht aan het Sint Elisabeth Verpleeg- en Gasthuis (EVG) in Amersfoort. Dit verpleeghuis is onderdeel van zorgorganisatie Beweging 3.0 en biedt zorg aan oudere mensen met dementie. Tijdens het werkbezoek stond centraal hoe een zorgorganisatie een kwaliteitsachterstand kan ombuigen naar kwalitatief goede zorg.

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

There are no news related to this product.